Lymph node yield as a measure of pancreatic cancer surgery quality

Introduction: Evaluated lymph node (ELN) yield has been established as a promising measure of surgical quality. Research has suggested that an ELN of at least 15 in pancreatic cancer patients is associated with improved survival and staging metrics. The aim of this study was to determine what impact...

Full description

Bibliographic Details
Main Authors: Kevin Zhao, Ayobami Fatunmbi, Shengxuan Wang, Katelyn Young, Rebecca L. Hoffman, Joseph A. Blansfield
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Surgery in Practice and Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S266626202200047X
_version_ 1798032278377463808
author Kevin Zhao
Ayobami Fatunmbi
Shengxuan Wang
Katelyn Young
Rebecca L. Hoffman
Joseph A. Blansfield
author_facet Kevin Zhao
Ayobami Fatunmbi
Shengxuan Wang
Katelyn Young
Rebecca L. Hoffman
Joseph A. Blansfield
author_sort Kevin Zhao
collection DOAJ
description Introduction: Evaluated lymph node (ELN) yield has been established as a promising measure of surgical quality. Research has suggested that an ELN of at least 15 in pancreatic cancer patients is associated with improved survival and staging metrics. The aim of this study was to determine what impact a high ELN yield of ≥15 has in a novel population. Methods: A retrospective cohort study was performed of patients with resectable, non-metastatic pancreatic adenocarcinoma who underwent neoadjuvant therapy followed by pancreatectomy using the National Cancer Database (NCDB 2004-2017). Patients who had <15 nodes examined and those who had ≥15 examined (high ELN) were compared. Univariate and multivariate analyses were performed to determine factors associated with ELN yield. A Cox proportional hazards model was used to identify factors associated with overall survival. Results: A total of 5,930 patients were included; 58% of patients had ≥15 lymph nodes examined. High ELN was associated with significant improvement in overall survival rates (p<0.004) and perioperative outcomes including post-operative stay (p<0.0001), 30-day unplanned readmission (p<0.028), and 90-day mortality (p<0.001). Patients who were treated at facilities with a high procedure-specific surgery volume were more likely to receive high ELN surgeries than those treated at facilities with a low volume (HR = 2.86[95% CI = 2.36-3.47]). Conclusions: An ELN yield of ≥15 was a significant measure of surgical quality in this novel population as it was associated with improvements in survival and perioperative outcomes. However, considerable harvest disparities exist at the facility level.
first_indexed 2024-04-11T20:11:32Z
format Article
id doaj.art-4579ac24aee446ea9e7a62597623987a
institution Directory Open Access Journal
issn 2666-2620
language English
last_indexed 2024-04-11T20:11:32Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Surgery in Practice and Science
spelling doaj.art-4579ac24aee446ea9e7a62597623987a2022-12-22T04:05:06ZengElsevierSurgery in Practice and Science2666-26202022-09-0110100103Lymph node yield as a measure of pancreatic cancer surgery qualityKevin Zhao0Ayobami Fatunmbi1Shengxuan Wang2Katelyn Young3Rebecca L. Hoffman4Joseph A. Blansfield5Geisinger Commonwealth School of Medicine, 525 Pine St., Scranton, PA 18510, United States; Corresponding author at: Geisinger Commonwealth School of Medicine, 525 Pine St., Scranton, PA 18510, United StatesGeisinger Medical Center, 100 N. Academy Ave., Danville, PA 17822, United StatesGeisinger Medical Center, 100 N. Academy Ave., Danville, PA 17822, United StatesGeisinger Medical Center, 100 N. Academy Ave., Danville, PA 17822, United StatesGeisinger Medical Center, 100 N. Academy Ave., Danville, PA 17822, United StatesGeisinger Medical Center, 100 N. Academy Ave., Danville, PA 17822, United StatesIntroduction: Evaluated lymph node (ELN) yield has been established as a promising measure of surgical quality. Research has suggested that an ELN of at least 15 in pancreatic cancer patients is associated with improved survival and staging metrics. The aim of this study was to determine what impact a high ELN yield of ≥15 has in a novel population. Methods: A retrospective cohort study was performed of patients with resectable, non-metastatic pancreatic adenocarcinoma who underwent neoadjuvant therapy followed by pancreatectomy using the National Cancer Database (NCDB 2004-2017). Patients who had <15 nodes examined and those who had ≥15 examined (high ELN) were compared. Univariate and multivariate analyses were performed to determine factors associated with ELN yield. A Cox proportional hazards model was used to identify factors associated with overall survival. Results: A total of 5,930 patients were included; 58% of patients had ≥15 lymph nodes examined. High ELN was associated with significant improvement in overall survival rates (p<0.004) and perioperative outcomes including post-operative stay (p<0.0001), 30-day unplanned readmission (p<0.028), and 90-day mortality (p<0.001). Patients who were treated at facilities with a high procedure-specific surgery volume were more likely to receive high ELN surgeries than those treated at facilities with a low volume (HR = 2.86[95% CI = 2.36-3.47]). Conclusions: An ELN yield of ≥15 was a significant measure of surgical quality in this novel population as it was associated with improvements in survival and perioperative outcomes. However, considerable harvest disparities exist at the facility level.http://www.sciencedirect.com/science/article/pii/S266626202200047XPancreatic adenocarcinomaLymph node harvestNeoadjuvant therapyEvaluated lymph node yieldSurgical quality improvementPerioperative outcomes
spellingShingle Kevin Zhao
Ayobami Fatunmbi
Shengxuan Wang
Katelyn Young
Rebecca L. Hoffman
Joseph A. Blansfield
Lymph node yield as a measure of pancreatic cancer surgery quality
Surgery in Practice and Science
Pancreatic adenocarcinoma
Lymph node harvest
Neoadjuvant therapy
Evaluated lymph node yield
Surgical quality improvement
Perioperative outcomes
title Lymph node yield as a measure of pancreatic cancer surgery quality
title_full Lymph node yield as a measure of pancreatic cancer surgery quality
title_fullStr Lymph node yield as a measure of pancreatic cancer surgery quality
title_full_unstemmed Lymph node yield as a measure of pancreatic cancer surgery quality
title_short Lymph node yield as a measure of pancreatic cancer surgery quality
title_sort lymph node yield as a measure of pancreatic cancer surgery quality
topic Pancreatic adenocarcinoma
Lymph node harvest
Neoadjuvant therapy
Evaluated lymph node yield
Surgical quality improvement
Perioperative outcomes
url http://www.sciencedirect.com/science/article/pii/S266626202200047X
work_keys_str_mv AT kevinzhao lymphnodeyieldasameasureofpancreaticcancersurgeryquality
AT ayobamifatunmbi lymphnodeyieldasameasureofpancreaticcancersurgeryquality
AT shengxuanwang lymphnodeyieldasameasureofpancreaticcancersurgeryquality
AT katelynyoung lymphnodeyieldasameasureofpancreaticcancersurgeryquality
AT rebeccalhoffman lymphnodeyieldasameasureofpancreaticcancersurgeryquality
AT josephablansfield lymphnodeyieldasameasureofpancreaticcancersurgeryquality